| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee2b4cf5180521e069e04d91bced4ff1 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4846
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1735
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-732
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-734 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0634
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3092
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-461
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2863 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K2-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 |
| filingDate |
2017-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8252a4c0a81403d397ba4fb470f4873d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f782242226dc1f72e5be3f65674f625
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29f7cf44b945caebe97f4a5d6483f8ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_369e14851097cf26ecfb09c52732b78a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d08886d9d07110c4422684166f92b3ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_075198fe37562b4a67c5e45dc053998d |
| publicationDate |
2017-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2017123879-A |
| titleOfInvention |
Use of human cells of myeloid leukemia origin for antibody expression |
| abstract |
The use of human cells of myeloid leukemia origin for the expression of antibodies is provided. The invention includes (a) introducing at least one nucleic acid encoding at least a portion of the protein into a host cell that is an immortalized human blood cell; and (b) introducing the host cell into the protein. It relates to a method of producing a protein molecule composition having a defined glycosylation pattern comprising culturing under conditions that permit production of the molecular composition; and (c) isolating said protein molecule composition. The present invention provides a new expression system for human immortalized blood cell lines, particularly cell lines of myeloid leukemia origin. The use of immortalized human blood cells is known in the prior art because such cells result in a glycosylation profile that differs from other known human cell lines derived from different tissues (eg, kidney or retina). Convenient compared to other systems. [Selection figure] None |
| priorityDate |
2006-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |